These medications represent the class of treatments called GLP-1 analogs, initially developed for treating type 2 glucose intolerance. Semaglutide, the specific version of this compound, has gained widespread https://kindpatchesglp1468083.blog5.net/96974254/comprehending-semaglutide-and-glp-1-receptor-agonists-the-in-depth-look